Radiation after surgery triples survival for a type of pediatric brain tumor

by St. Jude Children's Research HospitalPrincipal investigator Thomas Merchant, D.O. Ph.D., consults with an ependymoma patient at St. Jude. Credit: Seth Dixon / St. Jude Children's Resea

Updated on: May 20,2024

Radiation after surgery triples survival for a type of pediatric brain tumor

by St. Jude Children's Research HospitalPrincipal investigator Thomas Merchant, D.O. Ph.D., consults with an ependymoma patient at St. Jude. Credit: Seth Dixon / St. Jude Children's Resea

Updated on:May 20,2024

Turbocharging the body's natural killer cells to defeat cancer

by Monash UniversityDr. Jai Rautela and Professor Nicholas Huntington. Credit: Monash UniversityNatural Killer (NK) cells have long been the soldiers of the immune system that prevents the growth

Updated on: April 18,2024

Turbocharging the body's natural killer cells to defeat cancer

by Monash UniversityDr. Jai Rautela and Professor Nicholas Huntington. Credit: Monash UniversityNatural Killer (NK) cells have long been the soldiers of the immune system that prevents the growth

Updated on:April 18,2024

How colliding genetic processes drive aggressive cancers

byUniversity of Chicago Medical CenterLoss of CDK12 promotes large TD formation. Credit:Nature Cancer(2024). DOI: 10.1038/s43018-024-00848-4Cancer researchers at the University of Ch

Updated on: December 01,2024

How colliding genetic processes drive aggressive cancers

byUniversity of Chicago Medical CenterLoss of CDK12 promotes large TD formation. Credit:Nature Cancer(2024). DOI: 10.1038/s43018-024-00848-4Cancer researchers at the University of Ch

Updated on:December 01,2024

Overcoming the limits of immunotherapies

byUniversity of WürzburgKarl Petri (left) is setting up an Emmy Noether research group at the University Hospital of Würzburg with the support of the German Research Foundation. Alexandre Truber

Updated on: August 27,2024

Overcoming the limits of immunotherapies

byUniversity of WürzburgKarl Petri (left) is setting up an Emmy Noether research group at the University Hospital of Würzburg with the support of the German Research Foundation. Alexandre Truber

Updated on:August 27,2024

Pembrolizumab shows survival benefit for patients with renal cancer

by Elana GotkineFor patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months,

Updated on: May 11,2024

Pembrolizumab shows survival benefit for patients with renal cancer

by Elana GotkineFor patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months,

Updated on:May 11,2024

Study finds volume of liver resection during gallbladder surgery doesn't significantly affect overall survival

byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainGallbladder cancer is most common in people who have gallstones or have had gallstones in the past. While uncommon, most ga

Updated on: January 23,2024

Study finds volume of liver resection during gallbladder surgery doesn't significantly affect overall survival

byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainGallbladder cancer is most common in people who have gallstones or have had gallstones in the past. While uncommon, most ga

Updated on:January 23,2024

Video educates and connects men to prostate cancer screening options

byPerelman School of Medicine at the University of PennsylvaniaCredit: Unsplash/CC0 Public DomainAs part of a comprehensive effort to improve cancer screenings among diverse communities, Penn Me

Updated on: April 28,2024

Video educates and connects men to prostate cancer screening options

byPerelman School of Medicine at the University of PennsylvaniaCredit: Unsplash/CC0 Public DomainAs part of a comprehensive effort to improve cancer screenings among diverse communities, Penn Me

Updated on:April 28,2024

Research illuminates a therapeutic strategy to induce cancer cell death

by Rachel Sauer,CU Anschutz Medical CampusCredit: CC0 Public DomainCancer is a disease driven by gene mutations. These mutated genes in cancer fall into two major categories: tumor suppressors a

Updated on: January 22,2024

Research illuminates a therapeutic strategy to induce cancer cell death

by Rachel Sauer,CU Anschutz Medical CampusCredit: CC0 Public DomainCancer is a disease driven by gene mutations. These mutated genes in cancer fall into two major categories: tumor suppressors a

Updated on:January 22,2024

'3D mammography' almost halves the incidence of breast cancer between two screening tests in clinical trial

byUniversity of CórdobaDBT interval carcinoma. A 60-year-old asymptomatic patient who underwent a repeat mammographic study 20months after the screening study interpreted as normal due to

Updated on: March 30,2024

'3D mammography' almost halves the incidence of breast cancer between two screening tests in clinical trial

byUniversity of CórdobaDBT interval carcinoma. A 60-year-old asymptomatic patient who underwent a repeat mammographic study 20months after the screening study interpreted as normal due to

Updated on:March 30,2024

New research identifies a potential treatment target for hepatoblastoma, the most common liver cancer in children

byElsevierLeft: Gross images of livers from mice transfected with β-catenin and YAP1(β-Y), β-catenin and YAP1 plus dominant negative HSF1 (dnHSF1-β-Y) and normal (control). Right: Liver to body

Updated on: January 13,2024

New research identifies a potential treatment target for hepatoblastoma, the most common liver cancer in children

byElsevierLeft: Gross images of livers from mice transfected with β-catenin and YAP1(β-Y), β-catenin and YAP1 plus dominant negative HSF1 (dnHSF1-β-Y) and normal (control). Right: Liver to body

Updated on:January 13,2024

Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes

by University of California - San DiegoIn a patient-derived tumor model in mice, glioblastoma tumors (dark purple) shrink significantly when treated with both the MS drug teriflunomide and the ta

Updated on: May 05,2024

Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes

by University of California - San DiegoIn a patient-derived tumor model in mice, glioblastoma tumors (dark purple) shrink significantly when treated with both the MS drug teriflunomide and the ta

Updated on:May 05,2024

Study calculates contribution of risk factors to cancer in the US

by American Cancer SocietyPopulation attributable fraction of cancer deaths by risk factor; men, women, and combined. Credit: American Cancer SocietyA new American Cancer Society study calculates

Updated on: July 02,2024

Study calculates contribution of risk factors to cancer in the US

by American Cancer SocietyPopulation attributable fraction of cancer deaths by risk factor; men, women, and combined. Credit: American Cancer SocietyA new American Cancer Society study calculates

Updated on:July 02,2024